EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Platelet Activating Factor–Platelet Activating Factor Acetylhydrolase Enzyme Axis in Anaphylaxis: Current Evidence and Future Perspectives

Arianna Vignini iD, Sabrina Costanzo iD, Matteo Martini iD, Sonila Alia, Valentina Membrino iD, Tiziana Di Crescenzo, Elena Buti, Maria Beatrice Bilò

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27177783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Arianna Vignini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy. Hauptthemen laut MEDLINE: Platelet Activating Factor, Anaphylaxis, 1-Alkyl-2-acetylglycerophosphocholine Esterase. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaphylaxis is a severe systemic hypersensitivity reaction characterized by rapid onset, unpredictable clinical course, and potentially fatal outcomes. Although its diagnosis remains primarily clinical, the identification of biomarkers capable of improving risk stratification and understanding disease mechanisms remains an important unmet need. Among the mediators implicated in anaphylaxis, platelet-activating factor (PAF) has emerged as a key effector molecule involved in vascular permeability, bronchoconstriction, platelet activation, and cardiovascular dysfunction. The biological activity of PAF is tightly regulated by platelet-activating factor acetylhydrolase (PAF-AH), the enzyme responsible for its degradation, making the PAF–PAF-AH axis a potentially important determinant of reaction severity. OBJECTIVES: The present review summarizes current knowledge regarding the biology of PAF and PAF-AH and examines their role in the pathophysiology of anaphylaxis, with particular emphasis on Hymenoptera venom allergy (HVA). The therapeutic potential of targeting the PAF pathway is also discussed. Experimental and clinical evidence consistently suggests an association between increased PAF activity, reduced PAF-AH activity, and more severe anaphylactic reactions. However, methodological limitations, biological variability, and conflicting findings across studies currently limit the clinical applicability of these molecules as standalone biomarkers. Overall, the PAF–PAF-AH axis represents a biologically plausible link between molecular mechanisms and clinical severity in anaphylaxis. Further studies are required to standardize measurements, validate clinical utility, and define the role of this pathway as both a biomarker and therapeutic target; hence gaining insight into PAF’s role in various biological processes is critical.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Activating FactorAnaphylaxis1-Alkyl-2-acetylglycerophosphocholine EsteraseHumansAnimalsBiomarkersVenom Hypersensitivity

Stichwörter der Autor:innen

anaphylaxisbiomarkershymenoptera venom allergyplatelet-activating factor (PAF)platelet-activating factor acetylhydrolase (PAF-AH)therapeutic targets

Substanzen

Platelet Activating Factor1-Alkyl-2-acetylglycerophosphocholine EsteraseBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Sciences, Università Politecnica delle Marche, 60126 Ancona, Italy.
  • Postgraduate School of Allergy and Clinical Immunology, Marche Polytechnic University, 60126 Ancona, Italy.
  • Allergy Unit, Department of Internal Medicine, University Hospital AOU delle Marche, 60126 Ancona, Italy.
  • Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.

ORCID-Profile: Arianna Vignini, Sabrina Costanzo, Matteo Martini, Valentina Membrino

Zitieren

APA

Vignini, A., Costanzo, S., Martini, M., Alia, S., Membrino, V., Di Crescenzo, T., Buti, E., & Bilò, M. B. (2026). The Platelet Activating Factor–Platelet Activating Factor Acetylhydrolase Enzyme Axis in Anaphylaxis: Current Evidence and Future Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177783

Vancouver

Vignini A, Costanzo S, Martini M, Alia S, Membrino V, Di Crescenzo T, et al. The Platelet Activating Factor–Platelet Activating Factor Acetylhydrolase Enzyme Axis in Anaphylaxis: Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177783

BibTeX
@article{Vignini2026,
  author = {Vignini, Arianna and Costanzo, Sabrina and Martini, Matteo and Alia, Sonila and Membrino, Valentina and Di Crescenzo, Tiziana and Buti, Elena and Bilò, Maria Beatrice},
  title = {The Platelet Activating Factor–Platelet Activating Factor Acetylhydrolase Enzyme Axis in Anaphylaxis: Current Evidence and Future Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27177783}
}
Kostenlos starten →